Advanced search
Publication Cover
Leukemia & Lymphoma Volume 51, 2010 - Issue 4
Submit an article Journal homepage
185
Views
8
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Phase II study of autologous stem cell transplant using busulfan–melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphoma

Andrew P. GriggDepartment of Clinical Haematology and Bone Marrow Transplantation, Royal Melbourne Hospital and University of Melbourne, Melbourne, AustraliaCorrespondence[email protected]
,
Janey StoneCentre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australia
,
Alvin D. MilnerCentre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australia
,
Anthony P. SchwarerBone Marrow Transplant Service, Alfred Hospital, Melbourne, Australia
,
Max WolfDepartment of Haematology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia
,
H. Miles PrinceDepartment of Haematology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia
,
John SeymourDepartment of Haematology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia
,
Devinder GillDepartment of Haematology, Princess Alexandra Hospital, Brisbane, Australia
,
David EllisIntegrated Lymphoma Diagnostics, Flinders Medical Centre, Adelaide, Australia
,
John BashfordWesley Hospital, Brisbane, Australia
& On Behalf of the Australasian Leukaemia & Lymphoma Group show all
Pages 641-649 | Received 24 Nov 2009, Accepted 10 Jan 2010, Published online: 02 Jun 2010

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Philip Campbell, Adam Friebe, Paul Foulstone, Andrew Grigg, Jennifer Hempton & Ashish Bajel. (2012) Impact of palifermin on mucosal toxicity in autologous stem cell transplants using busulfan–melphalan conditioning chemotherapy for Hodgkin and non-Hodgkin lymphoma. Leukemia & Lymphoma 53:7, pages 1415-1416.
Read now

Articles from other publishers (7)

Christopher R. Flowers, Luciano J. Costa, Marcelo C. Pasquini, Jennifer Le-Rademacher, Michael Lill, Tsiporah B. Shore, William Vaughan, Michael Craig, Cesar O. Freytes, Thomas C. Shea, Mitchell E. Horwitz, Joseph W. Fay, Shin Mineishi, Damiano Rondelli, James Mason, Ira Braunschweig, Weiyun Ai, Rosa F. Yeh, Tulio E. Rodriguez, Ian Flinn, Terrance Comeau, Andrew M. Yeager, Michael A. Pulsipher, Isabelle Bence-Bruckler, Pierre Laneuville, Philip Bierman, Andy I. Chen, Kazunobu Kato, Yanlin Wang, Cong Xu, Angela J. Smith & Edmund K. Waller. (2016) Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes. Biology of Blood and Marrow Transplantation 22:7, pages 1197-1205.
Crossref
Eytan Stein & Ariella Noy. 2013. Fertility Preservation in Male Cancer Patients. Fertility Preservation in Male Cancer Patients 129 132 .
. 2013. Fertility Preservation in Male Cancer Patients. Fertility Preservation in Male Cancer Patients 104 171 .
P Kebriaei, T Madden, X Wang, P F Thall, C Ledesma, M de Lima, E J Shpall, C Hosing, M Qazilbash, U Popat, A Alousi, Y Nieto, R E Champlin, R B Jones & B S Andersson. (2012) Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL. Bone Marrow Transplantation 48:1, pages 26-31.
Crossref
Natthapol Songdej & Eric S. Winer. 2013. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma 247 266 .
. (2011) Current World Literature. Current Opinion in Oncology 23:2, pages 227-234.
Crossref
Partow Kebriaei, Timothy Madden, Reza Kazerooni, Xuemei Wang, Peter F. Thall, Celina Ledesma, Yago Nieto, Elizabeth J. Shpall, Chitra Hosing, Muzaffar Qazilbash, Uday Popat, Issa Khouri, Richard E. Champlin, Roy B. Jones & Borje S. Andersson. (2011) Intravenous Busulfan Plus Melphalan Is a Highly Effective, Well-Tolerated Preparative Regimen for Autologous Stem Cell Transplantation in Patients with Advanced Lymphoid Malignancies. Biology of Blood and Marrow Transplantation 17:3, pages 412-420.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.